Are gene polymorphisms related to adverse events of methotrexate in patients with rheumatoid arthritis? A retrospective cohort study based on an updated meta-analysis.
Polymorphisms and pharmacogenomics for the toxicity of methotrexate monotherapy in patients with rheumatoid arthritis: A systematic review and meta-analysis.
Folic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritis.
Clinical And Experimental Rheumatology
Davis, L A LA; Polk, B B; Mann, A A; Wolff, R K RK; Kerr, G S GS; Reimold, A M AM; Cannon, G W GW; Mikuls, T R TR; Caplan, L L
Correlation between polymorphisms of the reduced folate carrier gene (SLC19A1) and survival after pemetrexed-based therapy in non-small cell lung cancer: a North Central Cancer Treatment Group-based exploratory study.
Journal Of Thoracic Oncology : Official Publication Of The International Association For The Study Of Lung Cancer
Adjei, Araba A AA; Salavaggione, Oreste E OE; Mandrekar, Sumithra J SJ; Dy, Grace K GK; Ziegler, Katie L Allen KL; Endo, Chiaki C; Molina, Julian R JR; Schild, Steven E SE; Adjei, Alex A AA
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.
Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology
Adjei, Alex A AA; Mandrekar, Sumithra J SJ; Dy, Grace K GK; Molina, Julian R JR; Adjei, Araba A AA; Gandara, David R DR; Ziegler, Katie L Allen KL; Stella, Philip J PJ; Rowland, Kendrith M KM; Schild, Steven E SE; Zinner, Ralph G RG